Vita 34 AG
XETRA:V3V

Watchlist Manager
Vita 34 AG Logo
Vita 34 AG
XETRA:V3V
Watchlist
Price: 6.25 EUR -2.34% Market Closed
Market Cap: 110.3m EUR

Wall Street
Price Targets

V3V Price Targets Summary
Vita 34 AG

Wall Street analysts forecast V3V stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for V3V is 7.65 EUR with a low forecast of 7.58 EUR and a high forecast of 7.88 EUR.

Lowest
Price Target
7.58 EUR
21% Upside
Average
Price Target
7.65 EUR
22% Upside
Highest
Price Target
7.88 EUR
26% Upside
Vita 34 AG Competitors:
Price Targets
HEALTH
Nightingale Health Oyj
16% Downside
LFST
Lifestance Health Group Inc
27% Upside
KRSNAA
Krsnaa Diagnostics Ltd
65% Upside
EUDA
EUDA Health Holdings Ltd
134% Upside
4544
H.U. Group Holdings Inc
16% Upside
OPCH
Option Care Health Inc
8% Upside
AVAH
Aveanna Healthcare Holdings Inc
21% Upside
286A
EUCALIA Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Vita 34 AG

For the last 12 years the compound annual growth rate for Vita 34 AG's revenue is 14%. The projected CAGR for the next 5 years is 3%.

14%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Vita 34 AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is V3V's stock price target?
Price Target
7.65 EUR

According to Wall Street analysts, the average 1-year price target for V3V is 7.65 EUR with a low forecast of 7.58 EUR and a high forecast of 7.88 EUR.

What is Vita 34 AG's Revenue forecast?
Projected CAGR
3%

For the last 12 years the compound annual growth rate for Vita 34 AG's revenue is 14%. The projected CAGR for the next 5 years is 3%.

Back to Top